Bifidobacterium longum subsp. longum dipro-O: a potential therapeutic agent for ameliorating metabolic disorders in high-fat diet-induced obesity mouse model

Bifidobacterium longum subsp. longum dipro-O: a potential therapeutic agent for ameliorating metabolic disorders in high-fat diet-induced obesity mouse model

BackgroundExcessive fat intake results in lipid metabolic disorders accompanied by inflammation and other complications. However, the effectiveness of drug interventions for metabolic disorders is not ideal, owing to their inherent limitations. Here, we introduce the probiotic Bifidobacterium longum...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ning Xu, Jiang Luo, Weiyang Chen, Weiwei Xiang, Yue Zhai, Wei Jiang, Junlin Wu, Yanqing Hao, Meiru Chen, Qinghua Yu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Endocrinology
Subjects:	obesity lipid metabolism bifidobacterium longum blood glucose cholesterol triglyceride (TG)
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1519058/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Selection and in vitro Probiotic Properties of Bifidobacterium longum subsp. longum with Anti-diabetic Activity from the Intestinal Tract of Chinese Tajik Children
by: LI Si, AN Meiling, LI Longlong, ZHANG Ruirui, SUN Hailong, NI Yongqing
Published: (2025-05-01)

Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Program SAGA
by: V. T. Ivashkin, et al.
Published: (2024-12-01)

Clinical effects of Bifidobacterium Longum Subsp. Infantis YLGB-1496 on children with respiratory symptoms
by: Pin Li, et al.
Published: (2025-02-01)

Effectiveness of Bifidobacterium longum 35624 in the treatment of patients with irritable bowel syndrome: a systematic review
by: D. Andreev, et al.
Published: (2024-06-01)

Synergistic amelioration of obesity in high‐fat diet–fed mice by Bifidobacterium longum and green banana powder through targeting multiple pathways
by: Yi‐Yao Lu, et al.
Published: (2025-01-01)

Indole Derivatives Biosynthesis in Bifidobacterium longum subsp. infantis and the Tryptophan Substrate Availability
by: Shi‐Min Zhang, et al.
Published: (2025-06-01)

Multi-omics analyses the effect of Bifidobacterium longum subsp. longum BL21 supplementation on overweight and obese subjects: a randomized, double-blind, placebo-controlled study
by: Xiaoya Wang, et al.
Published: (2025-07-01)

Scientific Opinion on the substantiation of a health claim related to a combination of bifidobacteria (Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum) and decreasing potentially pathogenic intestinal microorganisms pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2009-12-01)

Effect of inulin on the growth and survival of Bifidobacterium longum BB536 in fermented goat’s and cow’s milk
by: Marina Šimunek, et al.
Published: (2009-09-01)

A novel source of phytochemical and bioactive peptide from fermented mushroom trimming waste extract by Bifidobacterium longum
by: Napassorn Peasura, et al.
Published: (2025-06-01)

Stress Resistance of Biofilm-type Bifidobacterium longum subsp. longum and Its Effect on Intestinal Microbiota
by: Shuang YAN, et al.
Published: (2025-08-01)

Bifidobacterium longum subsp. infantis CCFM1269 promotes intestinal barrier and release of IFN-β through TLR4-TRIF dependent way in growing mice
by: Mengfan Ding, et al.
Published: (2025-01-01)

Association of alterations in transcriptomics and intestinal immune responses with Bifidobacterium longum BAA2573 in improving dextran sulfate sodium-induced colitis
by: Wujuan Hao, et al.
Published: (2025-08-01)

Bifidobacterium longum JBLC-141 alleviates hypobaric hypoxia-induced intestinal barrier damage by attenuating inflammatory responses and oxidative stress
by: Xiang-Yang Li, et al.
Published: (2024-12-01)

Fexofenadine HCl enhances growth, biofilm, and lactic acid production of Limosilactobacillus reuteri and Bifidobacterium longum: implications for allergy treatment
by: Zainab Kamel Hammouda, et al.
Published: (2025-07-01)

Priority effects, nutrition and milk glycan-metabolic potential drive Bifidobacterium longum subspecies dynamics in the infant gut microbiome
by: Nicholas Pucci, et al.
Published: (2025-01-01)

Inhibitory effect of goat and cow milk fermented with Bifidobacterium longum bb-46 on growth of uropathogenic Candida albicans
by: Vedran Slačanac, et al.
Published: (2004-10-01)

Bifidobacterium longum subsp. infantis CCFM1426 enhances the anti-colitic effect of vitamin A via retinoic acid restoration and gut microbiota modulation in ulcerative colitis mice
by: Xihua Yu, et al.
Published: (2025-07-01)

Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis
by: Zhifeng Fang, et al.
Published: (2022-12-01)

Comparative in silico analyses between Lactiplantibacillus plantarum and Bifidobacterium longum concerning probiotic properties, anti-lipidemic, and anti-diabetic in vitro activities
by: Asmaa Negm El-Dein, et al.
Published: (2025-06-01)

Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11
by: Alexander Bertuccioli, et al.
Published: (2025-05-01)

Uptake of fucosylated type I human milk oligosaccharide blocks by Bifidobacterium longum subsp. infantis
by: Morten Ejby Hansen, et al.
Published: (2025-08-01)

Assessment of the efficacy of a feed additive consisting of Bifidobacterium longum CNCM I‐5642 (PP102I) for dogs (Nestlé Enterprises S.A.)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2025-03-01)

Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum M 20/5 and Bifidobacterium longum SP 07/3 and maintenance of upper respiratory tract defence against pathogens (ID 931, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2012-06-01)

Antibiotic Resistance in <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> and <i>Bifidobacterium longum</i>: Definition of Sensitivity/Resistance Profiles at the Species Level
by: Mario Terlizzi, et al.
Published: (2025-07-01)

Protective effects of Bifidobacterium longum subsp. longum BL21 against cyclophosphamide-induced reproductive dysfunction in zebrafish
by: Yao Dong, et al.
Published: (2025-04-01)

Propionibacterium freudenreichii co-inoculation enhances Bifidobacterium longum subsp. longum BB536 growth and metabolite content in soy whey
by: Ricco Tindjau, et al.
Published: (2025-09-01)

Molecular docking, drug-likeness properties, and toxicity prediction of alkaloidal phytoconstituents of piper longum against monoamine oxidase enzyme-A as an anti-depressive agent
by: Santosh Prasad Chaudhary kurmi, et al.
Published: (2025-05-01)

Amelioration of inflammatory bowel disease by Bifidobacterium animalis subsp. lactis XLTG11 in combination with mesalazine
by: Weiwei Ma, et al.
Published: (2024-12-01)

Antibacterial, antibiofilm, and wound healing activities of Piper longum root in multidrug-resistant Staphylococcus aureus infected mice
by: Pooja Gaur, et al.
Published: (2025-05-01)

Probiotic properties of an indigenous strain composition of <i>Bifidobacterium bifidum</i> ICIS-310 and <i>Bifidobacterium longum</i> ICIS-505 <i>in vitro</i>
by: N. B. Perunova, et al.
Published: (2025-06-01)

Probiotic Bifidobacterium longum Subsp. longum 51A Protects Mice from Genotoxic and Metabolic Alterations Induced by Subchronic Exposure to a Low-Dose Pesticide Cocktail
by: Mirna Maciel d’Auriol Souza, et al.
Published: (2025-08-01)

Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
by: Shunyu Yao, et al.
Published: (2021-01-01)

Untargeted metabolomic analysis uncovers metabolic variability of four Bifidobacterial strains for probiotic development
by: Kailong Liu, et al.
Published: (2025-01-01)

Piper Longum's Neuroprotective Role Against Amyloid-β and Okadaic Acid-Induced Toxicity in U87MG Cells Through the Lipocalin-2 Pathway
by: Seok-Hwan Sung, et al.
Published: (2025-06-01)

Stomatobaculum longum-Derived Extracellular Vesicles Enhance Oral Squamous Cell Carcinoma Malignancy Through BRCA1/EXO1/TP53BP1 Modulation
by: Yan L, et al.
Published: (2025-05-01)

Effect of Bifidobacterium longum subsp. infantis YLGB-1496 on common diseases in pediatrics: a randomized, blinded, placebo-controlled trial
by: Xi Zhang, et al.
Published: (2025-06-01)

Association between periodontitis and blood lipid levels: a cross-sectional study
by: Feiya Zhao, et al.
Published: (2025-07-01)

Understanding the probiotic health benefits of Bifidobacterium animalis subsp. lactis, BB-12™
by: Fergus W. J. Collins, et al.
Published: (2025-07-01)

Identification of anti-fibrotic compounds from Piper longum L via hollow fiber cell fishing and high-performance liquid chromatography with in vivo and in vitro validation
by: Jie Tian, et al.
Published: (2025-08-01)